Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and the 2023 Congress of the Schizophrenia International Research Society (SIRS)

EQS-News: Newron Pharmaceuticals S.p.A.


/ Key word: Conference/Study results





Newron presents exciting new data from study 014/015 at CINP World Congress of Neuropsychopharmacology and... | May 15, 2023

Related Keywords

United States ,Israel ,Japan ,Bresso ,Lombardia ,Italy ,South Korea ,Seika ,Kyongsang Bukto ,India ,Canada ,Montreal ,Quebec ,Germany ,Sri Lanka ,United Kingdom ,Switzerland ,Milan ,United Arab Emirates ,Australia ,Toronto ,Ontario ,Swiss ,America ,Paul Sagan ,Valentin Handschin ,Anne Hennecke Caroline Bergmann ,Stefan Weber ,Ravi Anand ,Mc Services ,Newron Pharmaceuticals ,Schizophrenia International Research Society ,Swiss Exchange ,World Congress ,European Union ,Supernus Pharmaceuticals ,Negative Syndrome Scale ,Clinical Global Impression ,Strauss Carpenter Levels ,Chief Medical Officer ,Strauss Carpenter Level ,Latin America ,Meiji Seika ,Ciara Martin ,Natalie Garland Collins ,Caroline Bergmann ,Newron Pharmaceuticalss Pa Stock Exchange ,News ,Information ,Press Release ,Onewron ,Pharmaceuticals ,Key ,Presents ,Exciting ,Few ,Data ,Rom ,Study ,It ,Vinp ,World ,Congress ,F ,Europsychopharmacology Nwrn It0004147952 ,